These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 4308767

  • 1. [Effects of streptomycin-resistance of Mycobacterium tuberculosis on induction rate of resistance to kanamycin, viomycin and capreomycin and on cross-resistance among these drugs].
    Nagata A, Mase M, Yamamoto M, Nakamura H.
    Kekkaku; 1969 Jun; 44(6):173-9. PubMed ID: 4308767
    [No Abstract] [Full Text] [Related]

  • 2. [Cross-resistance relationship among capreomycin, kanamycin, viomycin and streptomycin resistance of Mycobacterium tuberculosis].
    Tsukamura M, Toyama H, Mizuno S, Tsukamura S.
    Kekkaku; 1967 Oct; 42(10):399-404. PubMed ID: 4295935
    [No Abstract] [Full Text] [Related]

  • 3. [Evaluation of kanamycin, viomycin and capreomycin resistance of Mycobacterium tuberculosis].
    Tomoda T, Minami Y, Maekawa Y, Oi Y.
    Rinsho Byori; 1971 Jun; 19(6):423-6. PubMed ID: 4111341
    [No Abstract] [Full Text] [Related]

  • 4. [Cross resistance of Mycobacterium tuberculosis to streptomycin, kanamycin and viomycin].
    Makarevich NM, Mkrtchian SV, Afanas'eva IuP.
    Antibiotiki; 1970 Apr; 15(4):345-51. PubMed ID: 4321321
    [No Abstract] [Full Text] [Related]

  • 5. Cross-resistance relationships between capreomycin, kanamycin, and viomycin resistances in tubecle bacilli from paients.
    Tsukamura M.
    Am Rev Respir Dis; 1969 May; 99(5):780-2. PubMed ID: 4306213
    [No Abstract] [Full Text] [Related]

  • 6. Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin.
    McClatchy JK, Kanes W, Davidson PT, Moulding TS.
    Tubercle; 1977 Mar; 58(1):29-34. PubMed ID: 68613
    [Abstract] [Full Text] [Related]

  • 7. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM and TUM. I. The sensitivity of human tubercle bacilli isolated from patients to the five antibiotics (author's transl)].
    Saito T, Fukuhara Y.
    Kekkaku; 1974 Mar; 49(3):57-61. PubMed ID: 4136031
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Cross-resistance of tubercle bacilli (a review) (III) (author's transl)].
    Tsukamura M.
    Kekkaku; 1977 Apr; 52(4):171-5. PubMed ID: 69737
    [No Abstract] [Full Text] [Related]

  • 10. [Anti-bacterial activity of capreomycin, kanamycin, or viomycin against drug-resistant tubercle bacilli isolated from patients].
    Endo K.
    Jpn J Antibiot; 1971 Jun; 24(3):149-51. PubMed ID: 4327336
    [No Abstract] [Full Text] [Related]

  • 11. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.
    Maus CE, Plikaytis BB, Shinnick TM.
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3192-7. PubMed ID: 16048924
    [Abstract] [Full Text] [Related]

  • 12. [The degree of cross-resistance to kanamycin (KM) of tubercle bacilli resistant to capreomycin (CPM), and the degree of cross-resistance to KM and CPM of tubercle bacilli resistant to viomycin (VM) (author's transl)].
    Inagake H, Yamadori H, Inoue N, Mabuchi H, Ikeda N, Maekawa N.
    Kekkaku; 1980 Jul; 55(7):323-30. PubMed ID: 6162994
    [No Abstract] [Full Text] [Related]

  • 13. The fundamental studies on antituberculous activities of lividomycin.
    Gomi J, Aoyagi T, Torikai K, Yamada Y, Fujino T.
    Kekkaku; 1971 Jul; 46(7):265-9. PubMed ID: 4329783
    [No Abstract] [Full Text] [Related]

  • 14. Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis.
    Tsukamura M, Mizuno S.
    J Gen Microbiol; 1975 Jun; 88(2):269-74. PubMed ID: 50402
    [Abstract] [Full Text] [Related]

  • 15. [The experimental studies on antituberculous activity of lividomycin].
    Yamamoto K, Sakurai H, Inoue I, Yamagami K.
    Kekkaku; 1972 May; 47(5):135-8. PubMed ID: 4339540
    [No Abstract] [Full Text] [Related]

  • 16. [Pattern of capreomycin resistance of Mycobacterium tuberculosis].
    Tsukamura M, Toyama H.
    Kekkaku; 1968 May; 43(5):161-4. PubMed ID: 4971952
    [No Abstract] [Full Text] [Related]

  • 17. [Observations of the activity of capreomycin, cicloserine, kanamycin and streptomycin to clinical isolates of Mycobacterium tubercolosis].
    De Stasio A, Puccini G.
    Antibiotica; 1968 Dec; 6(4):358-62. PubMed ID: 4984521
    [No Abstract] [Full Text] [Related]

  • 18. [Development of resistance of Mycobacterium tuberculosis to cycloserine, ethionamide, kanamycin, florimycin in experiments in vitro].
    Mkrtchian SV.
    Antibiotiki; 1968 Oct; 13(10):907-10. PubMed ID: 4303355
    [No Abstract] [Full Text] [Related]

  • 19. [In vitro antituberculous activity of lividomycin].
    Kobayashi F, Nagoya T, Eda J, Yoshimura Y.
    Jpn J Antibiot; 1972 Dec; 25(6):360-6. PubMed ID: 4125073
    [No Abstract] [Full Text] [Related]

  • 20. [Studies on the effect of antituberculosis agents against tubercle bacilli in the resting state, using streptomycin-dependent strain (18-b). I. Studies in vitro].
    Ota Y.
    Kekkaku; 1971 Aug; 46(8):295-301. PubMed ID: 4328204
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.